Life after Cell Death—Survival and Survivorship Following Chemotherapy
Open Access
Abstract
To prevent cancer cells replacing and outnumbering their functional somatic counterparts, the most effective solution is their removal. Classical treatments rely on surgical excision, chemical or physical damage to the cancer cells by conventional interventions such as chemo- and radiotherapy, to eliminate or reduce tumour burden. Cancer treatment has in the last two decades seen the advent of increasingly sophisticated therapeutic regimens aimed at selectively targeting cancer cells whilst sparing the remaining cells from severe loss of viability or function. These include small molecule inhibitors, monoclonal antibodies and a myriad of compounds that affect metabolism, angiogenesis or immunotherapy. Our increased knowledge of specific cancer types, stratified diagnoses, genetic and molecular profiling, and more refined treatment practices have improved overall survival in a significant number of patients. Increased survival, however, has also increased the incidence of associated challenges of chemotherapy-induced morbidity, with some pathologies developing several years after termination of treatment. Long-term care of cancer survivors must therefore become a focus in itself, such that along with prolonging life expectancy, treatments allow for improved quality of life.Keywords
This publication has 169 references indexed in Scilit:
- Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemiaKorean Journal of Pediatrics, 2013
- Genomic Profiling Reveals the Potential Role of TCL1A and MDR1 Deficiency in Chemotherapy-Induced CardiotoxicityInternational Journal of Biological Sciences, 2013
- The Initial Hours of Metastasis: The Importance of Cooperative Host–Tumor Cell Interactions during Hematogenous DisseminationCancer Discovery, 2012
- Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer ChemotherapyClinical Cancer Research, 2012
- Chronic Diseases among Older Cancer SurvivorsJournal of Cancer Epidemiology, 2012
- Chemotherapy Enhances Metastasis Formation via VEGFR-1–Expressing Endothelial CellsCancer Research, 2011
- Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic CancerPLOS ONE, 2011
- Adriamycin NephropathyThe American Journal of Pathology, 2010
- Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care responseJournal of Cancer Survivorship, 2009
- Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous systemJournal of Biology, 2008